Upcoming Events
May 10, 2024 4:00 PM EDT
Engineered Staphylococcus Epidermidis as a Protein Delivery System for Treating Skin Diseases.
May 10, 2024 5:15 PM EDT
Staphylococcus epidermidis Strain Expressing LEKTI-D6 (ATR12-351) for Netherton Syndrome.
May 17, 2024 9:30 AM EDT
Cutaneous delivery of LEKTI via an engineered strain of Staphylococcus epidermidis for the treatment of Netherton syndrome.
May 17, 2024 9:30 AM EDT
Staphylococcus epidermidis for the topical treatment of epidermal growth factor receptor (EGFR) inhibitor-induced dermal toxicity.
May 17, 2024 5:00 PM EDT
Clinical study of Netherton syndrome treated topically with a Staphylococcus epidermidis strain expressing recombinant human LEKTI-D6 (ATR12-351).